Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section.

This study demonstrates the safety and efficacy of fondaparinux in women at high risk of VTE after cesarean section. Large phase trials comparing clinical outcomes with fondaparinux across a wide spectrum of patients are needed to confirm these observations.